Table 3. BAV and Aorta Characteristics according to the Presence of Specific Cardiomyopathy.
| No CM (n=1119) | DCM (n=10) | HCM (n=17) | LVNC (n=40) | p value | |
|---|---|---|---|---|---|
| BAV phenotypes | |||||
| Type 1 (RCC+LCC) | 713 (64) | 7 (70) | 10 (56) | 26 (65) | 0.934 |
| Type 2 (RCC+NCC) | 192 (17) | 1 (10) | 2 (11) | 8 (20) | 0.939 |
| Type 3 (LCC+NCC) | 62 (6) | 1 (10) | 0 (0) | 2 (5) | 0.653 |
| Type 0 (True) | 150 (13) | 1 (10) | 6 (30) | 4 (10) | 0.725 |
| BAV dysfunction | |||||
| No or mild dysfunction | 383 (34) | 6 (60)† | 5 (28) | 7 (18)*† | 0.048 |
| Significant AS | 481 (43) | 3 (30) | 9 (53) | 23 (58) | 0.080 |
| Significant AR | 354 (32) | 2 (20) | 6 (35) | 16 (40) | 0.308 |
| AV area by C.E. (cm2) | 1.60±0.35 | 1.69±0.34 | 1.50±0.35 | 1.57±0.36 | 0.249 |
| AV peak gradient (mm Hg) | 13.6±8.4 | 11.9±7.3 | 18.5±9.5 | 17.1±8.7 | 0.169 |
| Aorta phenotypes | |||||
| Normal shape | 388 (35) | 2 (20) | 6 (3) | 20 (50)* | 0.106 |
| Predominant Valsalva sinus | 162 (15) | 0 (0) | 4 (24) | 4 (10) | 0.597 |
| Predominant AA | 536 (48) | 7 (70) | 8 (47) | 16 (40) | 0.414 |
| Presence of aortopathy | 473 (42) | 5 (50) | 10 (59) | 16 (40) | 0.808 |
| AA diameter (mm) | 38.2±7.7 | 39.3±6.1 | 38.9±8.3 | 37.6±9.4 | 0.621 |
BAV, bicuspid aortic valve; CM, cardiomyopathy; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular noncompaction; RCC, right coronary cusp; LCC, left coronary cusp; NCC, non-coronary cusp; AS, aortic stenosis; AR, aortic regurgitation; AV, aortic valve; C.E., continuity equation; AA, ascending aorta.
Values are presented as mean±standard deviation or n (%) unless otherwise indicated.
*p<0.05 compared to the group with no CM; †p<0.05 compared to the DCM group.